18TH BIENNIAL MEETING OF THE EUROPEAN SOCIETY FOR IMMUNODEFICIENCIES
Centro de Congressos de Lisboa (CCL) *Lisbon, PORTUGAL Visit the Venue to read more
Dear Colleagues and Friends,
We are delighted to invite you to the 18th biennial ESID meeting to be held from 24-27 October, 2018, in Lisbon, Portugal. This meeting will be focusing on 'PID – From Fetus to Elderly'. It is being organized for you by the local and international scientific committee.
The ESID 2018 meeting in Lisbon will encompass the very latest exciting perspectives bridging basic and clinical research across primary immunodeficiency and related infection, autoimmunity and inflammation. A very stimulating and innovative programme brings together a unique faculty of internationally renowned clinicians and scientists to present and discuss significant and exciting developments in diagnostic immunology, genetics and immunobiology of primary immunodeficiencies, through keynote lectures, symposia, educational workshops, interactive sessions and meet-the-professor sessions.
The first day of the meeting will be dedicated to our highly acclaimed educational programme with further sessions throughout the meeting with world-class teachers bringing high quality educational lectures and interactive sessions which will be of great benefit to students, trainees and established clinicians and scientists with practical and relevant up-date current insights into pathogenesis, recognition and management of immune disorders.
We look forward to welcoming you to the beautiful and charming city of Lisbon, for an inspiring and cutting edge meeting bringing you the latest advances in the field.
With very best wishes,
Andrew Cant João Farela Neves
ESID President ESID 2018 Meeting Chair
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Authors will be required to select a topic (list of topics)
Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Meeting publications.
The presenting author is expected to attend the Meeting and present their abstract. Presenting authors of abstracts must be registered participants.
The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.
Abstracts must be submitted via this website only.
Abstracts must be received by the deadline May 15, 2018. Abstracts received after the deadline will not be considered.
You will receive confirmation that your abstract has been received, indicating the abstract number which it has been allocated. Please refer to this abstract number in all correspondence regarding the abstract.
Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 18th Biennial ESID Meeting
All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
Only abstracts with results will be accepted for review. Results may be preliminary, and the final results can be updated in the late breaking submission. Abstracts stating "data will be discussed in the presentation" will NOT be accepted.
Before submitting the abstract, the Abstract Submitter will be required to confirm the following:
I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
Submission of the abstract constitutes my consent to publication (e.g. Meeting website, programmes, other promotions, etc.)
The Abstract Submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content ("Content") provided to the 18th Biennial ESID Meeting and Kenes International (Hereafter: "The Organisers"). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
The Abstract Submitter grants the Organisers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the Content.
The Organisers reserve the right to remove from any publication an abstract which does not comply with the above.
I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.
Before you begin, please prepare the following information:
Presenting author's and Co-authors' details
Full first and family name(s).
Affiliation details: department, institution / hospital, city, state (if relevant), country, email address
Abstract title – limited to 25 words in UPPER CASE
Abstract text – limited to 250 words, including acknowledgements. We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words.
Abstracts should clearly state:
· Background and aims
Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word appears the first time.
Use generic names of drugs. Express numbers as numerals.
Abstract Topics – abstracts must be allocated to a specific category for the Scientific Programme. You will need to select the category most suited to your abstract. Tables – A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract.
Graphs and Images – A maximum of 2 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. Graphs and images may be uploaded in JPG, PNG and GIF format only. When including a table it is recommended to save the table as an image and then upload it in to the abstract.
After you submit your abstract, you can re-enter the submission link at any time to view and edit your abstract until the deadline date. Submitted abstracts cannot be modified or corrected after the submission deadline. There is no option to save the abstract as draft and to submit it at a later stage. If you do not submit your abstract, the information will be deleted.
Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.
Abstract submission deadline 2018-05-15
ESID Secretariat , Mr. , Kenes Group
ESID Secretariat , Mr. , Kenes Group